Blue Bell Private Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blue Bell Private Wealth Management's PFE Position: Q2 2026 in Review
Blue Bell Private Wealth Management increased its Pfizer (PFE) stake by 23% in Q2 2026, buying an estimated $41.2K and bringing the position to 8,388 shares worth $202K. The position accounts for 0.03% of the portfolio, ranked #280.
Blue Bell Private Wealth Management first reported a position in PFE in Q4 2013 and has held it in 31 quarters since. The position peaked at $809K in Q1 2015. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Blue Bell Private Wealth Management held 8,388 shares of Pfizer worth $202K as of Q2 2026.
- Blue Bell Private Wealth Management bought 1,576 Pfizer shares in Q2 2026, an estimated $41.2K.
- Pfizer made up 0.03% of Blue Bell Private Wealth Management's portfolio in Q2 2026, its #280 holding.
- Blue Bell Private Wealth Management first reported a position in Pfizer in Q4 2013 and has held it in 31 quarters since.
- Blue Bell Private Wealth Management's Pfizer position peaked at $809K in Q1 2015.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.